SI9200408A - Substituted 4(5)-amino-1,8-naphtyridine derivatives - Google Patents
Substituted 4(5)-amino-1,8-naphtyridine derivatives Download PDFInfo
- Publication number
- SI9200408A SI9200408A SI19929200408A SI9200408A SI9200408A SI 9200408 A SI9200408 A SI 9200408A SI 19929200408 A SI19929200408 A SI 19929200408A SI 9200408 A SI9200408 A SI 9200408A SI 9200408 A SI9200408 A SI 9200408A
- Authority
- SI
- Slovenia
- Prior art keywords
- group
- hydrogen
- alkyl group
- formula
- halo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919127252A GB9127252D0 (en) | 1991-12-23 | 1991-12-23 | Therapeutic agents |
| CN93109454A CN1096784A (zh) | 1991-12-23 | 1993-06-22 | 含取代4(5)-氨基-1,8-二氨杂萘的治疗剂 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI9200408A true SI9200408A (en) | 1993-09-30 |
Family
ID=36822317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI19929200408A SI9200408A (en) | 1991-12-23 | 1992-12-22 | Substituted 4(5)-amino-1,8-naphtyridine derivatives |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5464781A (cs) |
| EP (1) | EP0618916B1 (cs) |
| JP (1) | JP2527917B2 (cs) |
| CN (1) | CN1096784A (cs) |
| AT (1) | ATE171452T1 (cs) |
| AU (1) | AU656832B2 (cs) |
| BG (1) | BG98813A (cs) |
| CA (1) | CA2125858A1 (cs) |
| CZ (1) | CZ153594A3 (cs) |
| DE (1) | DE69227125T2 (cs) |
| FI (1) | FI943019A0 (cs) |
| GB (1) | GB9127252D0 (cs) |
| HR (1) | HRP921455A2 (cs) |
| HU (1) | HUT66971A (cs) |
| IL (1) | IL104169A0 (cs) |
| IN (1) | IN174405B (cs) |
| MX (1) | MX9207494A (cs) |
| NO (1) | NO942376L (cs) |
| NZ (1) | NZ246156A (cs) |
| SI (1) | SI9200408A (cs) |
| SK (1) | SK75094A3 (cs) |
| WO (1) | WO1993013097A1 (cs) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9312891D0 (en) * | 1993-06-22 | 1993-08-04 | Boots Co Plc | Therapeutic agents |
| GB9318931D0 (en) * | 1993-09-14 | 1993-10-27 | Boots Co Plc | Therapeutic agents |
| GB9420168D0 (en) * | 1994-10-06 | 1994-11-23 | Boots Co Plc | Therapeutic agents |
| AR004010A1 (es) | 1995-10-11 | 1998-09-30 | Glaxo Group Ltd | Compuestos heterociclicos |
| AU733551B2 (en) | 1996-09-25 | 2001-05-17 | Astrazeneca Ab | Qinoline derivatives inhibiting the effect of growth factors such as VEGF |
| RS49779B (sr) | 1998-01-12 | 2008-06-05 | Glaxo Group Limited, | Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze |
| US6166069A (en) * | 1998-05-12 | 2000-12-26 | American Home Products Corporation | Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| WO2001004111A1 (en) | 1999-07-09 | 2001-01-18 | Glaxo Group Limited | Anilinoquinazolines as protein tyrosine kinase inhibitors |
| US6933299B1 (en) | 1999-07-09 | 2005-08-23 | Smithkline Beecham Corporation | Anilinoquinazolines as protein tyrosine kinase inhibitors |
| EP1274692B1 (en) | 2000-04-07 | 2006-08-02 | AstraZeneca AB | Quinazoline compounds |
| US6534656B2 (en) * | 2001-05-31 | 2003-03-18 | North Carolina State University | Short synthesis of pyridine-based pharmaceutical intermediates |
| JP2003329989A (ja) * | 2002-03-06 | 2003-11-19 | Nippon Telegr & Teleph Corp <Ntt> | 光送信装置 |
| GB0230018D0 (en) | 2002-12-23 | 2003-01-29 | Syngenta Ltd | Fungicides |
| EP1660092A2 (en) | 2003-07-03 | 2006-05-31 | Myriad Genetics, Inc. | 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis |
| US8309562B2 (en) * | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
| KR100807920B1 (ko) | 2003-12-23 | 2008-02-27 | 화이자 인코포레이티드 | 신규한 퀴놀린 유도체 |
| EP1833482A4 (en) | 2005-01-03 | 2011-02-16 | Myriad Genetics Inc | COMPOUNDS AND ITS THERAPEUTIC USE |
| US8258145B2 (en) * | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
| US7763731B2 (en) * | 2005-12-21 | 2010-07-27 | Abbott Laboratories | Anti-viral compounds |
| EP1971611B1 (en) * | 2005-12-21 | 2012-10-10 | Abbott Laboratories | Anti-viral compounds |
| ES2378473T3 (es) * | 2005-12-21 | 2012-04-12 | Abbott Laboratories | Compuestos antivirales |
| EP2345652A1 (en) | 2005-12-21 | 2011-07-20 | Abbott Laboratories | Antiviral compounds |
| TWI392677B (zh) * | 2005-12-21 | 2013-04-11 | Abbott Lab | 抗病毒化合物、其製備方法及用途 |
| TWI399380B (zh) | 2006-12-20 | 2013-06-21 | Abbott Lab | 抗病毒化合物 |
| US20110269758A1 (en) * | 2008-07-03 | 2011-11-03 | Merck Patent Gmbh | Naphthyridinones as protein kinase inhibitors |
| EP2401275B1 (en) | 2009-02-24 | 2013-07-24 | Respiratorius AB | Naphthyridine derivatives having bronchodilating activity |
| WO2011063398A1 (en) * | 2009-11-23 | 2011-05-26 | Cylene Pharamaceuticals, Inc. | Polymorphs and salts of a kinase inhibitor |
| BR112012025167B1 (pt) | 2010-04-02 | 2024-01-09 | Firmenich Incorporated | Modificador de sabor doce |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4466965A (en) * | 1982-07-26 | 1984-08-21 | American Hospital Supply Corporation | Phthalazine compounds, compositions and use |
| NO174506B (no) * | 1984-10-30 | 1994-02-07 | Usv Pharma Corp | Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser |
| EP0222839A4 (en) * | 1985-05-17 | 1988-11-09 | Univ Australian | ANTI-MALARIA COMPOUNDS. |
| JPS6368568A (ja) * | 1986-09-10 | 1988-03-28 | Otsuka Pharmaceut Factory Inc | ｐ−アミノフエノ−ル誘導体 |
| DE3644825A1 (de) * | 1986-12-31 | 1988-07-14 | Basf Ag | Substituierte 1,8-naphthyridin-derivate und diese enthaltende fungizide |
| WO1989000571A2 (en) * | 1987-07-22 | 1989-01-26 | Schering Corporation | Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation |
| GB8804443D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| US4978661A (en) * | 1988-09-29 | 1990-12-18 | Innocenzo Caruso | Use of 6-halo-4-quinolone compounds and pharmaceutical compositions thereof for the preparation of a medicament for the therapeutical application in rheumatoid arthritis |
| GR900100380A (el) * | 1989-05-20 | 1991-10-10 | Fisons Plc | Μέ?οδος παρασκευής αντι-φλεγμονωδών παραγώγων αμινοφενόλης. |
| AU634561B2 (en) * | 1989-07-27 | 1993-02-25 | Eli Lilly And Company | Naphthyridine derivatives |
| JP2988739B2 (ja) * | 1990-04-16 | 1999-12-13 | 協和醗酵工業株式会社 | １，８−ナフチリジン−２−オン誘導体 |
| JP3157077B2 (ja) * | 1994-02-16 | 2001-04-16 | 内山工業株式会社 | ベアリングシール |
-
1991
- 1991-12-23 GB GB919127252A patent/GB9127252D0/en active Pending
-
1992
- 1992-10-12 US US08/244,369 patent/US5464781A/en not_active Expired - Lifetime
- 1992-12-12 DE DE69227125T patent/DE69227125T2/de not_active Expired - Fee Related
- 1992-12-12 CA CA002125858A patent/CA2125858A1/en not_active Abandoned
- 1992-12-12 NZ NZ246156A patent/NZ246156A/en unknown
- 1992-12-12 SK SK750-94A patent/SK75094A3/sk unknown
- 1992-12-12 JP JP5511397A patent/JP2527917B2/ja not_active Expired - Fee Related
- 1992-12-12 WO PCT/EP1992/002901 patent/WO1993013097A1/en active IP Right Grant
- 1992-12-12 AT AT93900052T patent/ATE171452T1/de not_active IP Right Cessation
- 1992-12-12 CZ CZ941535A patent/CZ153594A3/cs unknown
- 1992-12-12 HU HU9401877A patent/HUT66971A/hu unknown
- 1992-12-12 EP EP93900052A patent/EP0618916B1/en not_active Expired - Lifetime
- 1992-12-12 AU AU31587/93A patent/AU656832B2/en not_active Ceased
- 1992-12-17 IN IN758MA1992 patent/IN174405B/en unknown
- 1992-12-18 IL IL104169A patent/IL104169A0/xx unknown
- 1992-12-22 HR HR921455A patent/HRP921455A2/hr not_active Application Discontinuation
- 1992-12-22 MX MX9207494A patent/MX9207494A/es unknown
- 1992-12-22 SI SI19929200408A patent/SI9200408A/sl unknown
-
1993
- 1993-06-22 CN CN93109454A patent/CN1096784A/zh active Pending
-
1994
- 1994-05-31 BG BG98813A patent/BG98813A/bg unknown
- 1994-06-22 FI FI943019A patent/FI943019A0/fi not_active Application Discontinuation
- 1994-06-22 NO NO942376A patent/NO942376L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI943019A (fi) | 1994-06-22 |
| AU3158793A (en) | 1993-07-28 |
| MX9207494A (es) | 1993-07-01 |
| HUT66971A (en) | 1995-01-30 |
| CA2125858A1 (en) | 1993-07-08 |
| NO942376L (no) | 1994-06-22 |
| CN1096784A (zh) | 1994-12-28 |
| HRP921455A2 (en) | 1994-12-31 |
| NO942376D0 (cs) | 1994-06-22 |
| JP2527917B2 (ja) | 1996-08-28 |
| CZ153594A3 (en) | 1995-02-15 |
| IN174405B (cs) | 1994-11-26 |
| US5464781A (en) | 1995-11-07 |
| NZ246156A (en) | 1996-01-26 |
| HU9401877D0 (en) | 1994-09-28 |
| WO1993013097A1 (en) | 1993-07-08 |
| IL104169A0 (en) | 1993-05-13 |
| DE69227125T2 (de) | 1999-02-18 |
| DE69227125D1 (de) | 1998-10-29 |
| EP0618916B1 (en) | 1998-09-23 |
| SK75094A3 (en) | 1995-04-12 |
| ATE171452T1 (de) | 1998-10-15 |
| JPH07502280A (ja) | 1995-03-09 |
| BG98813A (bg) | 1995-05-31 |
| AU656832B2 (en) | 1995-02-16 |
| FI943019A0 (fi) | 1994-06-22 |
| GB9127252D0 (en) | 1992-02-19 |
| EP0618916A1 (en) | 1994-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI9200408A (en) | Substituted 4(5)-amino-1,8-naphtyridine derivatives | |
| US5780482A (en) | Condensed 4-aminopyridines with antirheumatic activity | |
| CN101906104B (zh) | 2-(吡啶-2-基氨基)-吡啶并[2,3-d]嘧啶-7-酮 | |
| CN102333771B (zh) | 作为crth2受体拮抗剂的吲哚衍生物 | |
| US20130303559A1 (en) | Benzimidazole and pyrazolopyridine derivatives for treating and/or preventing cardiovascular diseases | |
| JPH09291034A (ja) | 縮合ピリジン化合物およびその医薬としての用途 | |
| HU198047B (en) | Process for production of new condensated derivatives of pirrol and medical preparatives containing these compounds as active substances | |
| CN102791710A (zh) | 作为CaMKII激酶抑制剂用于治疗心血管疾病的5-氧代-5,8-二氢吡啶并[2,3-d]嘧啶衍生物 | |
| JPH05221989A (ja) | 複素環式化合物 | |
| CA1269103A (en) | Pyrido[1,2-a]pyrimidine derivatives | |
| JP2008501766A (ja) | 置換された三環式のベンゾイミダゾール | |
| JPH0212229B2 (cs) | ||
| CN104837827A (zh) | 吡啶酮衍生物及其在治疗结核病中的用途 | |
| TW576832B (en) | Quinolinecarboxylic acid derivative or salts thereof | |
| WO2007020426A1 (en) | Pyrazolone derivatives for the treatment of tuberculosis | |
| WO1995007909A1 (en) | Alkyl-1-alkyl-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxylates as anti-rheumatic agents | |
| CA2569913A1 (en) | Amino-halogen-imidazopyridines as proton pump inhibitors | |
| NZ501566A (en) | Pyrimidinyl-piperazinylalkylazole derivatives having anxiolytic and/or tranquilising properties useful for treatment of nausea | |
| JPH0977765A (ja) | ２−［（１ｈ−ベンズイミダゾール−２−イル）チオ メチル］−４−置換アミノ−５−ピリミジンカルボン 酸エステル誘導体 | |
| JPH0373549B2 (cs) | ||
| CN101563345A (zh) | 药物化合物 | |
| JPH03148259A (ja) | ピペラジン誘導体及びこれを含有する肝疾患治療剤 |